MDM2 and ovarian cancer: Though epidemiologic studies report no association or an inverse association between folate intake and ovarian cancer risk [67,70], FRα has been shown to increase chemotherapy resistance by stabilizing murine double minute 2 (MDM2), an oncogene that can be used as a prognostic factor in ovarian cancer [68,69].